We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.01B
AUM Growth
-$138M
Cap. Flow
-$174M
Cap. Flow %
-17.28%
Top 10 Hldgs %
26.38%
Holding
127
New
17
Increased
17
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$19.7M
2
GILD icon
Gilead Sciences
GILD
+$19.1M
3
LLY icon
Eli Lilly
LLY
+$16.1M
4
SO icon
Southern Company
SO
+$15.7M
5
HD icon
Home Depot
HD
+$15.2M

Top Sells

Rank Stock Value
1
RAI
Reynolds American Inc
RAI
+$26.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$20.3M
3
CME icon
CME Group
CME
+$18M
4
IBM icon
IBM
IBM
+$17.9M
5
KO icon
Coca-Cola
KO
+$14.3M

Sector Composition

Rank Sector Weight
1 Financials 15.74%
2 Technology 12.46%
3 Healthcare 10.79%
4 Consumer Staples 10.29%
5 Energy 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAI
126
DELISTED
Reynolds American Inc
RAI
– –
-403,771
Closed -$26.3M
OKS
127
DELISTED
Oneok Partners LP
OKS
– –
-187,500
Closed -$9.58M
2 3 4 5
6

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2017 Portfolio in Review

As of Q3 2017, Payden & Rygel held 127 positions worth $1.01B, down 12% from $1.14B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel withdrew a net $174M in Q3 2017, closing 9 positions and reducing 26 holdings. Its most notable exit was Reynolds American Inc, an estimated $26.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Payden & Rygel opened a new position in Texas Instruments worth $21.5M.

  • Payden & Rygel's largest Q3 2017 buy was Texas Instruments: 239,900 shares worth $21.5M.
  • Payden & Rygel added most to Gilead Sciences in Q3 2017, an estimated $19.1M increase.
  • Payden & Rygel's biggest Q3 2017 reduction was Johnson & Johnson, cutting an estimated $20.3M.
  • Payden & Rygel fully exited Reynolds American Inc in Q3 2017, selling an estimated $26.3M.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.01B portfolio in Q3 2017.
  • Payden & Rygel opened 17 new positions and closed 9 in Q3 2017.
  • Payden & Rygel's portfolio value fell 12% quarter-over-quarter to $1.01B.

Based on Payden & Rygel's 13F filing for Q3 2017, filed 14 Nov 2017.